Mark D. TrailSmith
Impact in
- Biotechnology top 10%
- Cancer Research and Treatments
-
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
-
- Cancer Research and Treatments 1
- Urology 1
- Periodontal Regeneration and Treatments 1
- Co-authors
- Robert S. Mittler (1 shared paper)Michael K. Hoffmann (1 shared paper)Kerry Klussman (1 shared paper)Barry S. Komm (1 shared paper)Peter V.N. Bodine (1 shared paper)R. Bruce Rutherford (1 shared paper)MARIA EMANUEL RYAN (1 shared paper)Marc Charette (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)Archives of Oral Biology (1 paper)The Journal of Experimental Medicine (1 paper)Journal of Bone and Mineral Research (1 paper)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (1 paper)
- Partner nations
- United States
In The Last Decade
Mark D. TrailSmith
8 papers receiving 444 citations
Peers
Comparison fields: 5 of 36
- Biotechnology 43
- Immunology 77
- Urology 16
- Biomaterials 24
- Genetics 12
Countries citing papers authored by Mark D. TrailSmith
This map shows the geographic impact of Mark D. TrailSmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. TrailSmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. TrailSmith more than expected).
Fields of papers citing papers by Mark D. TrailSmith
This network shows the impact of papers produced by Mark D. TrailSmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. TrailSmith. The network helps show where Mark D. TrailSmith may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. TrailSmith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 157 | |
| 2 | 1996 | 81 | |
| 3 | 1992 | 60 | |
| 4 | 2001 | 60 | |
| 5 | Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. | 1997 | 47 |
| 6 | Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin. | 1999 | 37 |
| 7 | 2002 | 26 | |
| 8 | 2000 | 6 |
About Mark D. TrailSmith
Mark D. TrailSmith is a scholar working on Biotechnology, Urology, Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 8 papers that have together received 474 indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (1 paper), T-cell and B-cell Immunology (1 paper), Periodontal Regeneration and Treatments (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Biotechnology (43 citations), Immunology (77 citations), Urology (16 citations), Biomaterials (24 citations) and Genetics (12 citations). Mark D. TrailSmith has collaborated with scholars based in United States. Frequent co-authors include Robert S. Mittler, Michael K. Hoffmann, Kerry Klussman, Barry S. Komm, Peter V.N. Bodine, R. Bruce Rutherford, MARIA EMANUEL RYAN, Marc Charette, Arris J. Henderson and Shirley J. Lasch. Their work appears in journals such as Journal of Medicinal Chemistry, Archives of Oral Biology, The Journal of Experimental Medicine, Journal of Bone and Mineral Research and Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.